Search for: "Takeda Pharmaceutical North America, Inc." Results 1 - 20 of 26
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jan 2012, 9:05 pm by Patent Docs
Mylan, Inc. et al. 1:12-cv-00024; filed January 3, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc.; Takeda Global Research and Development Center, Inc.; Watson Pharmaceuticals, Inc.; Andrx Labs, LLC • Defendants: Mylan, Inc.; Mylan Pharmaceuticals, Inc. [read post]
18 Sep 2011, 9:55 pm by Patent Docs
Accord Healthcare, Inc. 1:11-cv-06360; filed September 12, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc. [read post]
22 Feb 2014, 8:20 am
Takeda Pharmaceuticals North America Inc. et al alleges damages in excess of $75,000 after he says he developed bladder cancer because of his use of the drug for treatment of Type II diabetes. [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
(patent infringement) 12/2: Takeda Pharmaceutical Company Ltd. and Takeda Pharmaceutical North America Inc. v. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
(patent infringement) 11/6: Takeda Pharmaceutical Company Ltd. and Takeda Pharmaceuticals North America Inc. v. [read post]
10 Sep 2013, 8:18 pm by Mary Dwyer
Takeda Pharmaceuticals, Inc. [read post]
19 Sep 2011, 6:49 am by Darren Tobin
Notwithstanding the serious risk, the manufacturer of ACTOS, Takeda Pharmaceuticals North America Inc., has told reporters that the company remains positive about the drug. [read post]
17 Sep 2011, 5:43 am by Jonathan Rosenfeld
The lawsuit alleges that Actos' manufacturer, Takeda Pharmaceuticals North America (and other entities including: Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals Company Ltd., Takeda Pharmaceuticals America, Takeda San Diego Inc., Takeda Pharmaceuticals International Inc and Eli Lilly and Company), was negligent for not… [read post]
16 Jun 2011, 7:07 am by Mark Zamora
Food and Drug Administration today announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study designed to evaluate the risk of bladder cancer associated with use of this drug.The preliminary results are based on five-year data from an ongoing, 10-year observational study by the manufacturer, Takeda Pharmaceuticals North America Inc., San Diego. [read post]
5 Jan 2012, 3:10 pm by Ed Wallis
In August, Plaintiffs with pending lawsuits against Japanese company Takeda Pharmaceuticals America Inc. [read post]
4 Jan 2012, 9:20 am by Ed Wallis
In August, Plaintiffs with pending lawsuits against Japanese company Takeda Pharmaceuticals America Inc. [read post]